paroxetine has been researched along with Abnormalities, Congenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC | 1 |
| Ellfolk, M; Malm, H | 1 |
2 review(s) available for paroxetine and Abnormalities, Congenital
| Article | Year |
|---|---|
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Breast Feeding; Cardiovascular Abnormalities; Congenital Abnormalities; Female; Fluoxetine; Humans; Hypertension, Pulmonary; Infant, Newborn; Lactation; Maternal Exposure; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; PubMed; Respiratory Distress Syndrome, Newborn; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2010 |